Covid pushes India s Pharma industry growth to 59% in April
By IANS |
2 Views
India s pharma exports surge as tide turns against China Image Source: IANS News
Despite the widespread use of oral contraceptives (OCPs) by women, many are not aware that it may impair their ability to recognise others emotional expressions, which may have serious consequences in interpersonal contexts, suggests a new study. Image Source: IANS News
New Delhi, May 15 : The fresh wave of Covid-19 in the country has pushed up sales of medicines and resulted in exponential growth for the pharmaceutical sector.
According to total sales audit data from world s largest pharmaceutical market research firm IMS Health, the Indian Pharma Market (IPM) grew 59 per cent yoy in April, 2021 vs 16 per cent yoy in March, 2021 due to the low base effect in April, 2020 and sharp surge in Covid-19-related sales.
According to total sales audit data from world s largest pharmaceutical market research firm IMS Health, the Indian Pharma Market (IPM) grew 59 per cent yoy in April, 2021 vs 16 per cent yoy in March, 2021 due to the low base effect in April, 2020 and sharp surge in Covid-19-related sales.
Pandemic Pushes India s Pharma Industry Growth To 59% by Colleen Fleiss on May 15, 2021 at 10:29 PM
COVID-19 pandemic has pushed up sales of medicines and resulted in exponential growth for the pharmaceutical sector.
On the MAT (moving annual turnover) basis, IPM grew 9.6 per cent, primarily driven by pricing growth of 4.3 per cent and new product launch growth of 4.6 per cent. Volume growth was muted at 0.8 per cent.
According to a report from Emkay Global Financial Services, all major therapies posted high double-digit growth in April 21.
‘According to total sales audit data from world s largest pharmaceutical market research firm IMS Health, the Indian Pharma Market (IPM) grew 59 per cent yoy in April, 2021 vs 16 per cent yoy in March, 2021 due to the low base effect in April, 2020 and sharp surge in Covid-19-related sales.’
The fresh wave of Covid-19 in the country has pushed up sales of medicines and resulted in exponential growth for the pharmaceutical sector. According to total sales audit data from world s largest pharmaceutical market research firm IMS Health, the Indian Pharma Market (IPM) grew 59 per cent yoy in April, 2021 vs 16 per cent yoy in March, 2021 due to the low base effect in April, 2020 and sharp surge in Covid-19-related sales. On the MAT (moving annual turnover) basis, IPM grew 9.6 per cent, primarily driven by pricing growth of 4.3 per cent and new product launch growth of 4.6 per cent. Volume growth was muted at 0.8 per cent.